ERSPC Trial - PSA(prostate-specific Antigen)-based Prostate Cancer Screening in older Men

被引：0
|
作者：
Radtke, Jan Philipp [1 ,2 ]
Handke, Analena Elisa [3 ]
Haidl, Friederike [1 ]
Albers, Peter [1 ,4 ]
机构：
[1] Heinrich Heine Univ Dusseldorf, Univ Klinikum Dusseldorf, Med Fak, Klin Urol, Moorenstr 5, D-40225 Dusseldorf, Germany
[2] Deutsch Krebsforschungszentrum Dkfz, Abt Radiol, Heidelberg, Germany
[3] Klinikum Ruhr Univ Bochum, Marienhosp Herne, Klin Urol, Herne, Germany
[4] Deutsch Krebsforschungszentrum Dkfz, Abt Personalisierte Fruherkennung Prostatakarzinom, Heidelberg, Germany
来源：
UROLOGIE | 2024年
关键词：
D O I：
10.1007/s00120-024-02389-1
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Prostate-Specific Antigen (PSA) Screening for Prostate Cancer Revisiting the Evidence
    Carter, H. Ballentine
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (18): : 1866 - 1868
  • [2] Prostate-Specific Antigen Screening for Prostate Cancer in Older Men in the United States of America
    Black, Amanda
    Berg, Christine D.
    [J]. GERONTOLOGY, 2012, 58 (04) : 331 - 336
  • [3] Can prostate-specific antigen and prostate-specific antigen velocity be used for prostate cancer screening in men older than 70 years?
    Mouraviev, Vladimir
    Broadwater, Gloria
    Sun, Leon
    Mayes, Janice M.
    Moul, Judd W.
    Polascik, Thomas J.
    [J]. UROLOGY, 2008, 71 (06) : 1020 - 1023
  • [4] Update on prostate-specific antigen (PSA)-based screening
    Suzuki, Hiroyoshi
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2009, 16 (09) : 711 - 711
  • [5] Prostate-specific antigen velocity at low prostate-specific antigen levels as screening tool for prostate cancer:: Results of second screening round of ERSPC (Rotterdam)
    Roobol, MJ
    Kranse, R
    De Koning, HJ
    Schröder, FH
    [J]. UROLOGY, 2004, 63 (02) : 309 - 313
  • [6] Impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC) on prostate-specific antigen (PSA) testing by Dutch general practitioners
    Van der Meer, Saskia
    Kollen, Boudewijn J.
    Hirdes, Willem H.
    Steffens, Martijn G.
    Hoekstra-Weebers, Josette E. H. M.
    Nijman, Rien M.
    Blanker, Marco H.
    [J]. BJU INTERNATIONAL, 2013, 112 (01) : 26 - 31
  • [7] Prostate cancer and prostate-specific antigen (PSA) screening in AustriaProstatakarzinom und PSA-Screening in Österreich
    Christian Vutuc
    Eva S. Schernhammer
    Gerald Haidinger
    Thomas Waldhör
    [J]. Wiener klinische Wochenschrift, 2005, 117 : 457 - 461
  • [8] Prostate-specific antigen (PSA) and PSA density: Racial differences in men without prostate cancer
    Henderson, RJ
    Eastham, JA
    Culkin, DJ
    Kattan, MW
    Whatley, T
    Mata, J
    Venable, D
    Sartor, O
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (02) : 134 - 138
  • [9] Is prostate-specific antigen (PSA) screening indicated for any subgroup of men?
    Fisher, M
    [J]. JOURNAL OF FAMILY PRACTICE, 2002, 51 (02): : 113 - 113
  • [10] Inappropriate prostate-specific antigen (PSA) screening
    不详
    [J]. NEW ZEALAND MEDICAL JOURNAL, 2007, 120 (1266) : 133 - 134
12345